Bergen Stem Cell Consortium (BSCC) is a research initiative focused on stem cell research in Western Norway, supported by Helse Bergen health trust. The BSCC is formed by six research groups that work in the field of stem cell research and share the goal of generating basic scientific knowledge about the use of stem cells and introducing personalized stem cell-based treatment.
Our research group was represented by:
- Luiza Ghila talked about factors involved in pancreatic beta-cell regeneration
- Heidrun Vethe presented a quantitative proteomics analysis of differentiating human induced pluripotent stem cells
- Yngvild Bjørlykke showed how to use selected reaction monitoring to assess pathway activity during differentiation of human induced pluripotent stem cells
The meeting started with a key note presentation by Michele Cottler-Fox about the cord blood banking and the difficulties of working with embryonic stem cells in US; followed by the presentation of the Stem Cell Center in Oslo by Joel Glover. Susanna Miettinen showed how to use the autologous adipose stem cells to reconstruct cranio-maxillofacial hard-tissue defects, while Rosaria Giordano talked about the experience of the cell factory in ATMP manufacturing and clinical use. The key note presentation series was finished by Pedro Herrera discussion on in vivo transdifferentiation of pancreatic islet cells.